Difference between revisions of "CTSC:DFCIresources:LFIC"
From NAMIC Wiki
Line 1: | Line 1: | ||
[[CTSC:DFCIresources|Back to DFCI Imaging Resources]] | [[CTSC:DFCIresources|Back to DFCI Imaging Resources]] | ||
+ | |||
+ | |||
+ | ==Access/Eligibility== | ||
+ | Available to all investigators within the Harvard community. For cancer related research only | ||
+ | |||
+ | ==Equipment== | ||
+ | * Bruker Biospec 7T 30 cm bore MRI | ||
+ | * Siemens InVeon PET/CT | ||
+ | * Visual Sonics vevo 770 | ||
+ | * Xenogen IVIS spectrum (2) | ||
+ | * PXI Image Guided Irradiator | ||
+ | |||
+ | ==Barrier== | ||
+ | * Animal housing for available to (with veterinary care) | ||
+ | * Quarantine required to move live animals into facility | ||
+ | * Live animals cannot be removed from facility | ||
+ | * BL2 level biohazards allowed | ||
+ | |||
+ | ==Other== | ||
+ | *Mouse breeding management | ||
+ | *Full spectrum of mouse cancer models (GEMM, Primary xenografts, Cell line xenografts) | ||
+ | *Full treatment options (Expert technical support (7 days/week), Radiotherapy, longitudinal cancer treatment studies) | ||
+ | *Access to mouse histopathology | ||
+ | *Expert design and data analysis (Physicists, Cancer Biologists, Biostatistician, Clinicians, Data/Image Analysts) | ||
+ | *Radiotracer synthesis | ||
+ | |||
+ | ==Contact== | ||
+ | For information and to request access and services: | ||
+ | Andrew Kung: [mailto:Andrew_Kung@dfci.harvard.edu] |
Revision as of 20:29, 1 March 2011
Home < CTSC:DFCIresources:LFICBack to DFCI Imaging Resources
Access/Eligibility
Available to all investigators within the Harvard community. For cancer related research only
Equipment
- Bruker Biospec 7T 30 cm bore MRI
- Siemens InVeon PET/CT
- Visual Sonics vevo 770
- Xenogen IVIS spectrum (2)
- PXI Image Guided Irradiator
Barrier
- Animal housing for available to (with veterinary care)
- Quarantine required to move live animals into facility
- Live animals cannot be removed from facility
- BL2 level biohazards allowed
Other
- Mouse breeding management
- Full spectrum of mouse cancer models (GEMM, Primary xenografts, Cell line xenografts)
- Full treatment options (Expert technical support (7 days/week), Radiotherapy, longitudinal cancer treatment studies)
- Access to mouse histopathology
- Expert design and data analysis (Physicists, Cancer Biologists, Biostatistician, Clinicians, Data/Image Analysts)
- Radiotracer synthesis
Contact
For information and to request access and services: Andrew Kung: [1]